Antares Pharma Inc : Subcutaneous, Self-Administered Methotrexate for Rheumatoid Arthritis Demonstrated Significantly Greater Bioavailability over Current Standard of Care
It's not a new study. It's been going on for quite some time now.
What device was being used for the subcutaneous MTX? Was it otrexup?
Halle-frikin'-loo-yah....as opposed to booyah
This is definitely a confirmation of efficacy. Major league PR plus for ATRS. This ensures the riveted attention of the arthrtis community. Big deal!!!
Sentiment: Strong Buy
Many pt's are on therapy for RA, this will be a Big Winner
This is ABSOLUTELY a big deal, and I will be interested in watching the volume and price action this afternoon to see if the institutions start to react to this. Post-noon trading is often quite revealing.
good luck -
I am as long as long can be. But didn't we already know this. How about some new news.
New news will come - of that I am sure.
However in the meantime - all good things get us closer to our goal - appreciate them-
You may have known this but this is the kind of exposure that brings in new investors.